Leukemic Presentation of ALK+ Anaplastic Large Cell Lymphoma With a Novel Partner, Poly(A) Binding Protein Cytoplasmic 1 (PABPC1), Responding to Single-Agent Crizotinib

Haematologica - Italy
doi 10.3324/haematol.2018.215103

Related search